Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
United European Gastroenterol J ; 12(3): 299-308, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38193866

ABSTRACT

BACKGROUND: The International Collaboration on Cancer Reporting proposes histological tumour type, lymphovascular invasion, tumour grade, perineural invasion, extent, and dimensions of invasion as risk factors for lymph node metastases and tumour progression in completely endoscopically resected pT1 colorectal cancer (CRC). OBJECTIVE: The aim of the study was to propose a predictive and reliable score to optimise the clinical management of endoscopically resected pT1 CRC patients. METHODS: This multi-centric, retrospective International Budding Consortium (IBC) study included an international pT1 CRC cohort of 565 patients. All cases were reviewed by eight expert gastrointestinal pathologists. All risk factors were reported according to international guidelines. Tumour budding and immune response (CD8+ T-cells) were assessed with automated models using artificial intelligence. We used the information on risk factors and least absolute shrinkage and selection operator logistic regression to develop a prediction model and generate a score to predict the occurrence of lymph node metastasis or cancer recurrence. RESULTS: The IBC prediction score included the following parameters: lymphovascular invasion, tumour buds, infiltration depth and tumour grade. The score has an acceptable discrimination power (area under the curve of 0.68 [95% confidence intervals (CI) 0.61-0.75]; 0.64 [95% CI 0.57-0.71] after internal validation). At a cut-off of 6.8 points to discriminate high-and low-risk patients, the score had a sensitivity and specificity of 0.9 [95% CI 0.8-0.95] and 0.26 [95% 0.22, 0.3], respectively. CONCLUSION: The IBC score is based on well-established risk factors and is a promising tool with clinical utility to support the management of pT1 CRC patients.


Subject(s)
Artificial Intelligence , Colorectal Neoplasms , Humans , Retrospective Studies , Lymphatic Metastasis , Colorectal Neoplasms/surgery , Colorectal Neoplasms/pathology , Neoplasm Recurrence, Local/epidemiology
2.
J Pathol Inform ; 13: 100127, 2022.
Article in English | MEDLINE | ID: mdl-36268105

ABSTRACT

Computer-aided diagnostics in histopathology are based on the digitization of glass slides. However, heterogeneity between the images generated by different slide scanners can unfavorably affect the performance of computational algorithms. Here, we evaluate the impact of scanner variability on lymph node segmentation due to its clinical importance in colorectal cancer diagnosis. 100 slides containing 276 lymph nodes were digitized using 4 different slide scanners, and 50 of the lymph nodes containing metastatic cancer cells. These 400 scans were subsequently annotated by 2 experienced pathologists to precisely label lymph node boundary. Three different segmentation methods were then applied and compared: Hematoxylin-channel-based thresholding (HCT), Hematoxylin-based active contours (HAC), and a convolution neural network (U-Net). Evaluation of U-Net trained from both a single scanner and an ensemble of all scanners was completed. Mosaic images based on representative tiles from a scanner were used as a reference image to normalize the new data from different test scanners to evaluate the performance of a pre-trained model. Fine-tuning was carried out by using weights of a model trained on one scanner to initialize model weights for other scanners. To evaluate the domain generalization, domain adversarial learning and stain mix-up augmentation were also implemented. Results show that fine-tuning and domain adversarial learning decreased the impact of scanner variability and greatly improved segmentation across scanners. Overall, U-Net with stain mix-up (Matthews correlation coefficient (MCC) = 0.87), domain adversarial learning (MCC = 0.86), and HAC (MCC = 0.87) were shown to outperform HCT (MCC = 0.81) for segmentation of lymph nodes when compared against the ground truth. The findings of this study should be considered for future algorithms applied in diagnostic routines.

3.
Med Image Anal ; 79: 102473, 2022 07.
Article in English | MEDLINE | ID: mdl-35576822

ABSTRACT

Supervised learning is constrained by the availability of labeled data, which are especially expensive to acquire in the field of digital pathology. Making use of open-source data for pre-training or using domain adaptation can be a way to overcome this issue. However, pre-trained networks often fail to generalize to new test domains that are not distributed identically due to tissue stainings, types, and textures variations. Additionally, current domain adaptation methods mainly rely on fully-labeled source datasets. In this work, we propose Self-Rule to Multi-Adapt (SRMA), which takes advantage of self-supervised learning to perform domain adaptation, and removes the necessity of fully-labeled source datasets. SRMA can effectively transfer the discriminative knowledge obtained from a few labeled source domain's data to a new target domain without requiring additional tissue annotations. Our method harnesses both domains' structures by capturing visual similarity with intra-domain and cross-domain self-supervision. Moreover, we present a generalized formulation of our approach that allows the framework to learn from multiple source domains. We show that our proposed method outperforms baselines for domain adaptation of colorectal tissue type classification in single and multi-source settings, and further validate our approach on an in-house clinical cohort. The code and trained models are available open-source: https://github.com/christianabbet/SRA.


Subject(s)
Colorectal Neoplasms , Humans
4.
Histopathology ; 78(4): 476-484, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33001500

ABSTRACT

Tumour budding in colorectal cancer, defined as single tumour cells or small clusters containing four or fewer tumour cells, is a robust and independent biomarker of aggressive tumour biology. On the basis of published data in the literature, the evidence is certainly in favour of reporting tumour budding in routine practice. One important aspect of implementing tumour budding has been to establish a standardised and evidence-based scoring method, as was recommended by the International Tumour Budding Consensus Conference (ITBCC) in 2016. Further developments have aimed at establishing methods for automated tumour budding assessment. A digital approach to scoring tumour buds has great potential to assist in performing an objective budding count but, like the manual consensus method, must be validated and standardised. The aim of the present review is to present general considerations behind the ITBCC scoring method, and a broad overview of the current situation and challenges regarding automated tumour budding detection methods.


Subject(s)
Colorectal Neoplasms/classification , Practice Guidelines as Topic , Biomarkers/analysis , Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/pathology , Humans , Neoplasm Grading , Pathology, Clinical , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL
...